Leukemia inhibitor factor promotes functional recovery and oligodendrocyte survival in rat models of focal ischemia

Medicine and Dentistry

• Ischemia 100%
• Oligodendrocyte 100%
• Leukemia 100%
• Leukemia Inhibitory Factor 100%
• Apoplexy 60%
• Peroxiredoxin 4 60%
• In Vitro 20%
• Stem Cell 20%
• Secretion (Process) 20%
• Cytokine 20%
• Oxidative Stress 20%
• Cell Survival 20%
• Infarction 20%
• Cord Blood 20%
• Cell Therapy 20%
• Cell Signaling Pathway 20%
• Incubation 20%
• Lactate Dehydrogenase 20%
• Akt Signaling 20%
• Antioxidant Capacity 20%
• Superoxide Dismutase 20%
• Middle Cerebral Artery Occlusion 20%
• White Matter Injury 20%
• Umbilical Cord Blood Cell 20%
• Neutralizing Antibody 20%
• Pleiotropy 20%
• Protein Kinase B 20%
• Treatment Modality 20%

Neuroscience

• Leukemia Inhibitory Factor 100%
• Oligodendrocyte 100%
• Ischemia 100%
• Peroxiredoxin 4 60%
• Cerebrovascular Accident 60%
• Cell Signaling 20%
• Antioxidant 20%
• In Vitro 20%
• Oxidative Stress 20%
• Stem Cell 20%
• Cell Survival 20%
• Superoxide Dismutase 20%
• Lactate Dehydrogenase 20%
• Middle Cerebral Artery 20%
• Cell Therapy 20%
• Neutralizing Antibody 20%
• Cytokine 20%

Immunology and Microbiology

• Rat Model 100%
• Leukemia Inhibitory Factor 100%
• Neutralizing Antibody 20%
• Umbilical Cord Blood 20%
• White Matter 20%
• Oligodendrocyte Culture 20%
• Stem Cell 20%
• Cell Survival 20%
• Secretion (Process) 20%
• Infarct Volume 20%
• Akt Signaling 20%
• Umbilical Cord Blood Cell 20%
• Cytokine 20%
• Oxidative Stress 20%
• Middle Cerebral Artery 20%
• Pleiotropy 20%
• Superoxide Dismutase 20%
• In Vitro 20%